// App-Quantinova.ai

PB0849 : Modelling the Cost of Equivalent trough Level across Gene Therapy and Factor IX Replacement Therapy in Haemophilia B

Researchers

Presenter

  • G. Pedra

Principal Investigators

  • S. Mehdi

  • N. Misciattelli

  • S. Kar

  • T. Burke

Medical Centers

  • HCD Economics, Daresbury, United Kingdom

  • ADC Therapeutics, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved